Literature DB >> 19117782

Immunological diagnosis of human angiostrongyliasis due to Angiostrongylus cantonensis (Nematoda: Angiostrongylidae).

Praphathip Eamsobhana1, Hoi Sen Yong.   

Abstract

Angiostrongylus cantonensis-associated eosinophilic meningitis in humans has been commonly reported worldwide. However parasitologically confirmed cases are not common, as the parasite has been recovered only infrequently from the cerebrospinal fluid of patients. The potential value of immunodiagnosis is therefore self-evident. Immunological tests can also help in the differential diagnosis of parasitic (particularly helminths) infections that cause eosinophilic meningitis. This paper summarizes the state of and advances in the immunological diagnosis of human angiostrongyliasis due to Angiostrongylus (= Parastrongylus) cantonensis. A specific antigen is available for the definitive diagnosis and unequivocal differentiation of eosinophilic meningitis due to helminth infections. Rapid diagnostic kits based on dot-blot ELISA have been developed and have proved to be simple, effective, and economical for field use.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19117782     DOI: 10.1016/j.ijid.2008.09.021

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  20 in total

Review 1.  Human Angiostrongylus cantonensis: an update.

Authors:  Q-P Wang; Z-D Wu; J Wei; R L Owen; Z-R Lun
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-07-05       Impact factor: 3.267

2.  Anti-N-methyl-D-aspartate receptor encephalitis associated with intracranial Angiostrongylus cantonensis infection: a case report.

Authors:  Yu Peng; Xiaojia Liu; Suyue Pan; Zuoshan Xie; Honghao Wang
Journal:  Neurol Sci       Date:  2016-10-24       Impact factor: 3.307

Review 3.  Clinical aspects of eosinophilic meningitis and meningoencephalitis caused by Angiostrongylus cantonensis, the rat lungworm.

Authors:  Gerald S Murphy; Stuart Johnson
Journal:  Hawaii J Med Public Health       Date:  2013-06

4.  A severe case of Angiostrongylus eosinophilic meningitis with encephalitis and neurologic sequelae in Hawa'i.

Authors:  Edward Kwon; Tomas M Ferguson; Sarah Y Park; Augustina Manuzak; Yvonne Qvarnstrom; Stephen Morgan; Paul Ciminera; Gerald S Murphy
Journal:  Hawaii J Med Public Health       Date:  2013-06

5.  Expression of recombinant antigenic proteins from Angiostrongylus cantonensis: a brief report.

Authors:  Alessandra L Morassutti; Andrey Perelygin; Keith Levert; Seh-Ching Lin; Yeuk-Mui Lee; Alexandre J da Silva; Patricia P Wilkins; Carlos Graeff-Teixeira
Journal:  Hawaii J Med Public Health       Date:  2013-06

Review 6.  Angiostrongyliasis in Thailand: epidemiology and laboratory investigations.

Authors:  Praphathip Eamsobhana
Journal:  Hawaii J Med Public Health       Date:  2013-06

7.  Molecular diagnosis of eosinophilic meningitis due to Angiostrongylus cantonensis (Nematoda: Metastrongyloidea) by polymerase chain reaction-DNA sequencing of cerebrospinal fluids of patients.

Authors:  Praphathip Eamsobhana; Darawan Wanachiwanawin; Naowarat Dechkum; Anchana Parsartvit; Hoi Sen Yong
Journal:  Mem Inst Oswaldo Cruz       Date:  2013-02       Impact factor: 2.743

8.  The 31-kDa antigen of Angiostrongylus cantonensis comprises distinct antigenic glycoproteins.

Authors:  Alessandra L Morassutti; Keith Levert; Andrey Perelygin; Alexandre J da Silva; Patricia Wilkins; Carlos Graeff-Teixeira
Journal:  Vector Borne Zoonotic Dis       Date:  2012-08-27       Impact factor: 2.133

Review 9.  Update on eosinophilic meningoencephalitis and its clinical relevance.

Authors:  Carlos Graeff-Teixeira; Ana Cristina Arámburu da Silva; Kentaro Yoshimura
Journal:  Clin Microbiol Rev       Date:  2009-04       Impact factor: 26.132

10.  Identification and characterization of an asparaginyl endopeptidase from Angiostrongylus cantonensis.

Authors:  Shih-Hsin Chang; Kuang-Yao Chen; Lian-Chen Wang
Journal:  Parasitol Res       Date:  2014-04-03       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.